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1. INTWOE)UGTIQN 
It has long been known that nonhistone nuclear pro- 
teins are unusually rich in aspartic and glutamic acids 
[l-3]. Kuehl et al. [4] demonstrated that nonhistone 
chromosomal proteins are rich in highly charged, acidic 
oligopeptides up to 12 residues in length, and more 
rarely contain very long peptides consisting exclusively 
of acidic residues such as are found in the nonhistone 
chromosomal proteins HMG 1 and HMG2. In addition 
several authors have reported that the acidic domains, 
largely distributed in the nuclear nonhistone proteins, 
frequently contain additional negative charges as phos- 
phoserine or phosphothreonine [5-IO]. The enzyme re- 
sponsiblc fcbr the phosphorylation of serine or threonine 
within acidic sequences is the protein kinase NII [I 11. 
The phosphorylation of these acidic protein domains by 
protein kinase NII appears to be involved in the 
modulation of protein activity and in the DNA-protein 
interaction. 
containing pyroGlu-Ala-Glu-Ser-Asn. In this work we 
have phosphorylated this pentapeptide by protein ki- 
nase NH, isolated from calf thymus chromatin, in order 
to obtain a peptide model to study the possible interac- 
tions between acidic protein domains and DNA. 
2. MATERIALS AND METHODS 
2. I. PurlQ%acarion of nuclear Nil base 
We have isolated a family of DNA-binding acidic 
phosphorylated oligopeptides controlling transcription 
‘in vitro’ and in several cell cultures [12-141. The bio- 
chemical characterization of these peptides shows the 
presence of a blocked N-terminus which is probably 
represented by pyroglutamic acid [ 15,16], 
Nuclear NII kinase was purified from calf thymus. Fresh thymus 
‘was quick-frozen and stored in liquid nitrogen. Samples of 250 g were 
homogenized with a Potter homogenizer in 5 vols of solutidn con- 
sisting of 20 mM Tris-HCI (pH 7.5), 0.3 M sucrose, 1.5 mM MgC12, 
0.5 mM phenylmethylsulfonyltluoride (PMSF). After centrifugation 
at 4000 x g for I5 min, the pelleted chromatin was suspended in 1 I 
of the homogenization buffer containing 1.4 M sucrose and cen- 
trifugcd at 8000 x g for I.5 h. The pellet was washed once with 
homogenization buffer and was subsequently extracted with 10 mM 
Tris-HCI (pH 8.0), 0.35 M N&I, OS mM PMSF. The extract was 
centrifuged overnight at IO0 000 x g and the supernatant was frac- 
tionated with ammonium sulfate. The 30-50% saturated fraction was 
solubilized in 30 ml of SO mM Tris-HCI (pH X.0), 25% glycerol, 5 mM 
MgC&, 0.1 mM EDTA, 0.2 mM PMSF and subjected to DEAE- 
phosvitin-Sepharosc- and phosphocellulosc chromatography as de- 
scribed by Inouc et al. [I I]. 
On the basis of the available biochemical informa- 
tion WC have designed and synthctizcd a pentapeptide 
Cu~~~~~~t&lr,lre address: D. Amici, Dcpartmcnt of Molcclar. Cellular 
and Animal Biology. University 0r Camtlrino, 2, via F. Camcrirri. 
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Protein clcctrophorctic analysis of thecnzymc preparation was per- 
formed in sodium dodccyl sulhtc (SDS) polyacrylamide gels (10%)) as 
dcscribcd by Lacmmli [l7]. The gel, silverastaincd with a kit from 
BioJXad, shows polypcptidc bands at 44 kDa, 3G kDa and 27 kDa. 
Autophosphorylalioli of the 27 kDa subunit was obscrvcd following 
incubation of the purified kinasc with [y”“P]ATP under normal condi- 
tions ofphosphoryla~ion. The activity ofthc kinasc NII isolated from 
calf thymus chromatin is stron$ly inhibited by hcparh at conccntra 
tians below I pll/ml. 
The arsity mirrturc for kinarc ‘acGvi(y conrained SO mM ‘his-HCI 
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The pentapeptide pyroGlu-Ala-Glu-Ser-Asn has been synthetized and phosphorylated in vitro at level ofserine by protein kinase NII isolated from 
calf thymus chromatin. It is noteworthy that the calf thymus kinase NII shows a remarkable affinity for this peptide. The [32P]peptide is able to 
bind to several DNAs in the presence of Mg” (2 phagc, calf thymus. pBR540 plasmid). This binding appears not specific wit.h regard to the type 
of DNA and its base sequence. These data support ihe hypothesis that phosphorylated acidic domains of nuclear nonhistone proteins could bind 
directly to DNA in the presence of Mg2’ cations 
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(pH g), 10 mM MgCI,, 50 mM NaCl, lo-2Opg of casein (or phosvitin 
or other substrate), 5 /Zi of [y-‘2P]ATP, and enzyme in a final volume 
of 0.1 ml. The sarnules were incubated at 37°C for 20 min, and the 
reaction was stopped by the addition of 1 rn: 10% trichloroacetic acid 
plus 1.5% (w/v) pyrophosphate. The precipitates were collected on 
nitrocellulose filters and washed twice with 2 ml portions of trichloro- 
acetic acid-pyrophosphate. Wradioactivity was determined by Ce- 
renkov counting. 
The phosphorylstion of synthetic psptide pyroGlu-Ala-Glu-Ser- 
Asn and other peptide analogues was performed with the same phos- 
phorylation mixture; following incubation at 37OC for 20 min, ali- 
quots were applied directly onto &Xii-GphOi& cellulose plates in 
order to isolate the phosphorylated compound. 
In control experiments the synthetic basic peptide Leu-Arg-Arg- 
Ala-Ser-Leu-Gly (Kemptide) (Serva, Heidelberg) was phosphorylated 
in vitro by 3’4’-CAMP-dependent protein kinase (Sigma). The phos- 
phorylation procedure and the isolation of phospharylated peptide 
were performed according to Kemp et al. [21]. 
2.3. Synthesis and pu@ication ofpeptides 
The peptides, reported in Table I, were synthesized by solution 
methods using a stepwise procedure. The benzyloxycarbonyl group 
was selected for temporary protection of the a-amino group, while the 
t-butyl ester was reserved for permanent protection of the carboxy 
groups. In the coupling reaction, the pentafIuorophenyl esters of the 
protected amino acid were employed. The 2 group was removed by 
catalytic hydrogenolysis. All protected intermediates were purified by 
crystallization until homogeneous in thin-layer chromatography. The 
final removal of protecting groups was performed with trifluoroacetic 
acid for 30 min at room temperature. The free peptides were purified 
by preparative reverse phase I-IPLC in 0.1% trifluoroacetic acid with 
2-propanol gradient. 
3. RESULTS AND DISCI_JSSIQN 
After incubation of synthesized pentapeptide (pyro- 
Glu-Ala-Glu-Ser-Asn) with the protein kinase NII, 
about 80 yl of the phosphorylation mixture containing 
2Opg of peptide were subjected to thin layer electropho- 
resis, and subsequently the plate was analyzed by auto- 
radiography. The result shows that the protein kinase 
isolated from calf thymus chromatin has remarkable 
affinity for the pentapeptide (Table I); it is evident hat 
Table I 
Phosphorylation of synthetic peptidcs by calf thymus protein kinase 
NII 
Substrate Relative phosphorylation 
rate 
pyroGlu-Ala-Glu-Scr-Asn 100 
m-Ala-Glu-Scr-Asn 66 
pyroGIu-Ala-$&Ser-Asn 55 
pyroGlu-Ale-Glu-Ser4&!! 
pyroGlu-Ala-Glu-Scr ;1: 
Lcu-Arg-Arg-Ala-Scr-Lcu-Gly ND 
AcScr-NH, ND 
The concentration of all substrates was 2 mM. The incubation time 
was 20 min, lhc phosphorylation rutcs are relative to that of the 
peptidc pyroGlu-Ala.Glu-Scr-Asn (100%) (K, 4 mM. V,,, 173 mnol 
*mgmin”), The pbosphorylat.ion of the pcptidcs was performed 
and cstimatcd as described under Materials and Methods, ND, not 
-f-l 
Q 10 20 3Q 
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Fig. 2. Chromatography on Scphadcx GIO of the in vitro phosphory- 
lated pentapeptide extrctcd from cltctrophoretic plate. The column (1 
x 30 cm) was equilibrated ilnd eluted with double-distilled water. The 
pattern of the “P-radioactivity elution is repwed; the peak corre- 
detectable, spondr to column void velurne. 
Fig. 1. Autoradiogram of high-voltage preparative lectrophoresis of 
the pentapeptide pyroGlu-Ala-Glu-Ser-Asn phosphorylated in vitro 
by kinase WI. The elcctrophoresis was performed on cellulose thin 
layer plates (20 x 20 cm) for 2 h at 600 V, in acetic acid/formic 
acid/water/acetone (&:2:75: 15 by vol., PI-I 1.9). 
almost all the radioactive phosphate is rapidly trans- 
ferred (Fig. 1). The kinetic data of the pentapeptide 
phosphorylation (Table I) are comparable with other 
synthetic peptides phosphorylated by proteim kinase 
NII as reported by Meggio et al. [ 181 and Litchfield et 
al. [19]. The specificity of phosphorylation efficiency 
has been demonstrated by utilizing a series of peptide 
analogues; the data reported in Table I show clearly 
that 3 requirements are important for the peptide phos- 
phorylation; (i) the asparagine on the C-terminal posi- 
tion of serine residue; (ii) the glutamic acid (negative 
charge) on the N-terminal position of serine residue; 
and (iii) the blocked peptide I’d-terminus (absence of 
positive charge). The synthetic pcntapeptide and its 
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Fig. 3. Time-course of/z phap DNA transcription in vitro by E. coli 
RNA polymerase utilizing a nucleotides/salt conventional mixture 
[12]: incorporation of 13H]UMP t3H]UTP, Amersham, 12.3 Wmmol). 
Determination of radioactivity incorporated into the acid-soluble 
fraction was carried out as reported in [12]. Control, no peptide; 
samples treated with [32P]pentapeptidecorresponding to 0.32 prnol (I), 
0.96 pm01 (2) and 4.X pm01 (3, respectively. 
analogues are not phosphorylated by 3’-5’-cAMP-de- 
pendent protein kinass (data not shown). 
The phosphorylated peptide has been extracted from 
the cellulose by 50 mM ammonium bicarbonate. After 
lyophilization (twice) the 32F-labeled peptide was puri- 
fied by gel filtration OR Sephadex GIO (Fig. 2). The 
radioactivity of the in vitro phosphorylated peptide 
1 2 
Fig. 4. Binding of”‘P-peptide IO pBRS40 DNA in presence of 10 mM 
MgCI1, Following incubation with phosphorylated peptide ( (I) 1.6 
pmols or (2) 3.2 pmol) in 10 mM Tris-HCI, pH 7.5, (30 ,uI) with or 
without 10 mM MgCI,, the pBR540 was precipitated by addition of 
0,I M sodium acetate and 2 vols of cold ethanol. The pellet was 
washed once with 70% ethanoV309b water and subsequently the “P- 
radioactivity was measured in the supcrnatant and in the pellet. 
eluted at void volume was measured by Cerenkov coun- 
ting: 2.8 x IO7 cpm. To confirm that the phosphoryla- 
tion by protein kimase NII occurs at the level of serine, 
an aliquot of the phosphorylated peptide has been par- 
tially hydrolyzed in 6 N HCl for 3 h at 110°C. The 
hydrolysate was mixed with phosphoserine standard, 
applied onto a cellulose sheet and subjected to ascen- 
dent thin layer chromatography in n-butanoVpyridine/ 
acetic acid/ water (6:X3:3, by volume). Unlabeled phos- 
phoserime was stained with ninhydrin and 32P-radioac- 
tivity was detected by autoradiography. The results con- 
firm the presence of radioactive phosphoseriae in the 
phosphopeptide (data not shown). 
The phosphorylated peptide causes a sharp dose-de- 
pendent inhibition of ib phage DNA transcription in 
vitro by E. coli RNA polymerase (Fig. 3). Pt is note- 
worthy that unphosphorylated peptide does not impair 
the transcription rate even at high concentrations (up to 
5 ,ug of peptide/_64g DNA). 
In order to investigate if the transcription is inhibited 
through binding of the 32P-peptide to the DNA, the in 
vitro phosphorylated peptide was incubated with il 
phage and calf thymus DNA in the presence or absence 
of MgCl,; considering that the transcription mixture 
contains M$+ cations. Subsequently the DNA was pre- 
cipitated by the addition of 0.1 M sodium acetate and 
2 vols of ethanol and the 3zP-radioactivity measured in 
the pellet and in the supernatant. 
Table II 
Binding of in vitro phosphorylated peptide to calf thymus and fl phage 
DNA 
Precipitation by ethanol 
DNA 32P-peptide MgC], Pellet Supernatant 
2/Q (cpm) (mM) @pm) @pm) 
calf thymus 50 000 41 265 13 685 
100 000 ;x 68 018 27 580 
200 000 10 117 891 90 536 
50 000 0 2 516. 49 861 
100 000 0 2 243 111.540 
200 000 0 3 746 186 332 
II phage 50 000 10 47 13.5 9 501 
100 000 
I’: 
87 068 16 293 
400 000 188 675 235 927 
800 000 10 362 727 452 162 
50 000 0 1 324 46 419 
100 000 1 480 101 110 
400 000 8 4 213 390 819 
800 000 0 3 724 803 631 
Following incubation with phosphorylated peptide in 10 mM Tris- 
MCI, pH 7.5, (30 ~1) in presence (or absence) of IO mM MgClr the 
DNA was precipitated by addition ofO.l M sodium acetate and 2 ~01s 
of cold ethanol. The pellet was washed once with 70% ethanoY30% 
water and subsequently the >rP-radioactivity was measured in the 
supernatant and in the pellet. Considering the Cerenkov counting 
efficiency, 100 000 cpm correspond to 3.2 pmol of “P-peptidc. 
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Fig. 5. Time-course of PBR540 DNA transcription in vitro by f?. coli 
RNA polymerase utilizing a nucleotide/salt conventional mixture [12]: 
incorporation of [‘HIUMP. Determination of radioactivity incor- 
porated into the acidic-insoluble fraction was carried out as reported 
in [12]. pBR540 plasmid DNA (2 fig) was incubated with phosphory- 
lated peptide in presence of MgClz as described in the legend of Table 
II and the DNA-peptide complexes precipitated with ethanol, resolu- 
bilized and transcribed. Control DNA (0); DNA in presence of 3zP- 
peptide, I .6 pmols (A) and 3.2 pmols (w). 
The results reported in Table II show that the phos- 
phorylated peptide is able to bind to DNA and the 
presence of Rag’+ cations is necessary for the binding. 
Furthermore we have demonstrated that the unphos- 
phorylated pentapeptide is not able to compete with the 
phosphorylated. form for binding to DNA. The specifi- 
city of Mg’+-mediated binding between DNA and phos- 
phorylated acidic peptides is supported by experiments 
demonstrating that the basic phosphorylated heptapep- 
tide Leu-Arg-Arg-Ala-Ser-Leu-Gly is not able to bind 
to DNA in the absence or presence of Mg”’ cations 
(data not shown). 
The DNA binding ability of the [32P]pcntapeptide 
(pyroGlu-A!a-Glu-Ser-Asn) has in addition been con- 
firmed with the pBRS40 DNA plasmid (Fig. 4). The 
[32P]- peptide-pBRS40 DNA complex was subsequently 
tested as template in the transcription reaction per- 
formed in vitro with E. coli RNA polymerase. The bind- 
ing with the peptide strongly decreased the template 
capacity of DNA (Fig. 5). This binding appears not to 
be specific with regard to the type of DNA and its base 
sequence, and it probably occurs through a bridge 
formed by Mg”’ cations. 
The results presented in this work support the hypo- 
thesis that phosphorylated acidic domains of nuclear 
proteins can bind directly to DNA in the presence of 
Mgzf cations. This possibility appears interesting be- 
cause the most general idea is that acidic proteins bind 
to chromatin through electrostatic interactions with the 
histones [20]. Another interesting point is that the phos- 
phorylated pentapeptide shows some functional charac- 
teristics very similar to those of the acidic peptides we 
isolated, thus representing a molecular model which 
may be developed and improved to obtain synthetic 
peptides able to reproduce the biological activity shown 
by the peptide fraction controlling DNA transcription 
in vitro and RNA synthesis in several cell systems [12- 
161. 
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